1. Luo, Yongwen, Zhou, Jun, Tang, Jianing, Liu, Tongzu, Liu, Tao. 2021. MINDY1 promotes bladder cancer progression by stabilizing YAP. In Cancer cell international, 21, 395. doi:10.1186/s12935-021-02095-4. https://pubmed.ncbi.nlm.nih.gov/34315490/
2. Xia, B L, Liu, K W, Huang, H X, Wang, B, Gao, J. . [Deubiquitinating enzyme MINDY1 is an independent risk factor for the maintenance of stemness and poor prognosis in liver cancer cells]. In Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 31, 518-523. doi:10.3760/cma.j.cn501113-20230130-00028. https://pubmed.ncbi.nlm.nih.gov/37365029/
3. Sahoo, Gaurav, Bandyopadhyay, Shruti, Tripathi, Ekta, Karyala, Prashanthi. 2024. Deubiquitinating enzymes in breast cancer: in silico analysis of gene expression and metastatic correlation. In Journal of biomolecular structure & dynamics, , 1-10. doi:10.1080/07391102.2024.2439046. https://pubmed.ncbi.nlm.nih.gov/39671715/
4. Song, Xingchao, Li, Wenjin, Tian, Chunyan, Yang, Weibin, Zhou, Jiahua. 2024. Study on the mechanism of liver cancer immune escape mediated by MINDY1 through regulation of PD-L1 ubiquitination level. In Biomolecules & biomedicine, 25, 144-154. doi:10.17305/bb.2024.10962. https://pubmed.ncbi.nlm.nih.gov/39217442/
智鼠故事 
